Subscribe to RSS
DOI: 10.1055/s-0043-118534
Quality Standards for Herbal Drugs and Herbal Drug Preparations – Appropriate or Improvements Necessary?
Publication History
received 29 May 2017
revised 28 July 2017
accepted 14 August 2017
Publication Date:
29 August 2017 (online)
Abstract
Standards for quality control as defined in the European Pharmacopoeia contribute significantly to a consistent and high quality of herbal drugs, herbal drug preparations, and herbal medicinal products. The minimum content of single plant constituents is considered of high relevance. Therefore, nearly all monographs on herbal drugs or herbal drug preparations contain an obligatory assay.
However, a critical evaluation of the data published for such assayed constituents reveals that in most cases these constituents have to be considered as purely analytical markers without correlation to quality or efficacy. Examples where the assay does not meet its objective support the need to adapt current quality standards. Moreover, the trend to increase the content of certain constituents may lead to significant modifications to traditional manufacturing processes.
In order to initiate a scientific discussion, the role of the assay in the context of quality requirements, quality documentation in the manufacturing process, safety, and efficacy is discussed and possible alternatives to the single marker assay are examined.
-
References
- 1 European Pharmacopoeia. 9th ed. Strasbourg: Council of Europe; 2016
- 2 Österreichisches Arzneibuch. Wien: Verlag Österreich; 2016
- 3 Pharmacopoeia of the Peopleʼs Republic of China. Beijing: China Medical Science Press; 2010
- 4 Overview of assessment work – priority list. Doc. Ref. EMA/HMPC/278067/2006. EMA; 2017. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/12/WC500017724.pdf Accessed July 4, 2017
- 5 Reflection paper on markers used for quantitative and qualitative analysis of herbal medicinal products and traditional herbal medicinal products. Doc. Ref. EMEA/HMPC/253629/2007. EMA; 2008. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003196.pdf Accessed July 4, 2017
- 6 Guideline on the quality of herbal medicinal products/traditional herbal medicinal products. Doc. Ref. EMA/CPMP/QWP/2819/00 Rev. 2. EMA; 2011. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/09/WC500113209.pdf Accessed July 4, 2017
- 7 Guideline on specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products/traditional herbal medicinal products. Doc. Ref. EMA/CPMP/QWP/2820/00 Rev. 2. EMA; 2011. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/09/WC500113210.pdf Accessed July 4, 2017
- 8 Guideline of the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and of community herbal monographs/entries to the community list for traditional herbal medicinal products/substances/preparations. Doc. Ref. EMEA/HMPC/104613/2005. EMA; 2006. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003644.pdf Accessed July 4, 2017
- 9 Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Doc. Ref. 2001L0083 – EN – 16.11.2012 – 011.001 – 1. European Commission; 2012. Available at http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02001L0083-20121116&qid=1472567249742&from=EN Accessed July 4, 2017
- 10 Assessment report on Aesculus hippocastanum L., semen. Doc. Ref.: EMEA/HMPC/225304/2008. EMA; 2009. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2010/01/WC500059103.pdf Accessed July 4, 2017
- 11 Community herbal monograph on Aesculus hippocastanum L., semen. Doc. Ref.: EMEA/HMPC/225319/2008. EMA; 2009. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2010/01/WC500059105.pdf Accessed July 4, 2017
- 12 Community herbal monograph on Hypericum perforatum L. herba (well-established use). Doc. Ref.: EMA/HMPC/101304/2008. EMA; 2009. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2010/01/WC500059145.pdf Accessed July 4, 2017
- 13 Community herbal monograph on Hypericum perforatum L. herba (traditional use). Doc. Ref.: EMEA/HMPC/745582/2009. EMA; 2009. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2010/01/WC500059149.pdf Accessed July 4, 2017
- 14 Runkel F, Prenner L, Häberlein H. Ein Beitrag zum Wirkmechanismus von Efeu. Pharm Ztg 2005; 150: 19-25
- 15 Assessment report on Hedera helix L. folium. Doc. Ref. EMA/HMPC/586887/2014. EMA; 2015. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2016/01/WC500199887.pdf Accessed July 4, 2017
- 16 Stauss-Grabo M. Untersuchungen zur Pharmakokinetik des Efeu-Saponins α-Hederin in Ratten [Dissertation]. Marburg: Philipps-Universität; 2008
- 17 Stauss-Grabo M, Häberlein H, Runkel F. EFEU – Ein modernes Phytopharmakon. Pharm Unserer Zeit 2008; 37: 484-485
- 18 Schmidt O. Biopharmazeutische Charakterisierung von Efeublättertrockenextrakten durch in vivo und in vitro Studien [Dissertation]. Heidelberg: Ruprecht-Karls-Universität; 2003: 109-210
- 19 Sticher O, Heilmann J, Zündorf I. eds. Hänsel/Sticher Pharmakognosie Phytopharmazie. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2015: 621-622
- 20 Assessment report on Cimicifuga racemosa (L.) Nutt., rhizoma. Doc. Ref. EMA/HMPC/3968/2008. EMA; 2010. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2011/05/WC500106358.pdf Accessed July 4, 2017
- 21 Avula B, Wang YH, Smillie TJ, Khan IA. Quantitative determination of triterpenoids and formononetin in rhizomes of Black Cohosh (Actaea racemosa) and dietary supplements by using UPLC-UV/ELS detection and identification by UPLC-MS. Planta Med 2009; 75: 381-386
- 22 Assessment report on Panax ginseng C.A. Meyer, radix. Doc. Ref. EMA/HMPC/321232/2012. EMA; 2014. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2014/05/WC500167385.pdf Accessed July 04, 2017
- 23 Ginseng dry extract, quantified. Pharmeuropa 2010; 22.3: 286-288 Available at http://pharmeuropa.edqm.eu/PharmeuropaArchives/ Accessed July 4, 2017
- 24 Bensky D, Clavey S, Stöger E. Chinese Herbal Medicine. Materia Medica. Seattle: Eastland Press; 2004: 710-714
- 25 Wang JS, Wu YG. eds. Chinese Wild Mountain Ginseng, Zhongguo yeshan renshen . Hangzhou: Zhejiang kexue jishu chubanshe; 1999
- 26 Zhang GJ. ed. The Learning of Commercial Products of Traditional Chinese Medicine, Zhongyao shangpinxue . Beijing: Renmin weisheng chubanshe; 2002: 104-112
- 27 Soldati F, Tanaka O. Panax ginseng: relation between age of plant and content of ginsenosides. Planta Med 1984; 50: 351-352
- 28 Blaschek W, Hilgenfeldt U, Holzgrabe U, Mörike K, Reichling J, Ruth P. HagerROM 2016. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2016
- 29 Carneiro DM, Freire RC, Honório TC, Zoghaib I, Cardoso FF, Tresvenzol LM, de Paula JR, Sousa AL, Jardim PC, da Cunha LC. Randomized, double-blind clinical trial to assess the acute diuretic effect of Equisetum arvense (field horsetail) in healthy volunteers. Evid Based Complement Alternat Med 2014; 2014: 760683
- 30 Pallag A, Bungau S, Tit DM, Jurca T, Sirbu V, Honiges A, Horhogea C. Comparative study of polyphenols, flavonoids and chlorophylls in Equisetum arvense L. populations. Rev Chim (Bucharest) 2016; 67: 530-533
- 31 Coumarin in flavourings and other food ingredients with flavouring properties. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC). (Question No EFSA-Q-2008–677). Adopted on July 8, 2008. The EFSA Journal 2008; 793: 1-15 Available at http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/793.pdf Accessed July 4, 2017
- 32 Risk assessment of coumarin intake in the Norwegian population. Opinion of the Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics of the Norwegian Scientific Committee for Food Safety. October 13, 2010. Available at. http://www.vkm.no/dav/271c242c20.pdf Accessed July 4, 2017
- 33 Stahl-Biskup E, Nagell A, Loew D. Meliloti herba. In: Blaschek W. ed. Wichtl. Teedrogen und Phytopharmaka. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2016: 414-416
- 34 Reflection paper on the risks associated with furocoumarins contains in preparations of Angelica archangelica L. Doc. Ref. EMEA/HMPC/317913/2006. EMA 2007. Available at. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003648.pdf Accessed July 4, 2017
- 35 Li SZ. Systematic Materia Medica (Bencao gangmu). Shanghai: Shanghai hongbaoji yinhang; 1916
- 36 Xia GH, Wang QL, Hou JL, Song QY, Luo-Lin. Zhang DD, Yang X. Effects of different concentrations of nitrogen and phosphorus on growth and active components of Salvia miltiorrhiza . Zhongguo Zhong Yao Za Zhi 2016; 41: 4175-4182
- 37 Zhao ZG, Gao SR, Hou JL, Wang WQ, Xu ZG, Song Y, Zhang XM, Li J. Influence of different original processing methods on quality of Salvia miltiorrhiza . Zhongguo Zhong Yao Za Zhi 2014; 39: 1396-1400
- 38 Pang XJ. The classification standards of traditional quality for Chinese herbs are not to be neglected (Bu yinggai hushi chuantong de zhongyao zhiliang pingjia biaozhun), Zhongyao tiandiwang. 2013 Available at http://zyctd.com/zixun/204/9455.html Accessed July 04, 2017
- 39 Afzal M, Al-Hadidi D, Menon M, Pasek J, Dhami MSI. Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol Drug Interact 2001; 18: 159-190
- 40 Xie P, Ma S, Tu P, Wang Z, Stoeger E, Bensky D. The prospect of application of extractive reference substance of Chinese herbal medicines. Chin Med 2013; 4: 125-136
- 41 Combarieu E, Martinelli EM, Pace R, Sardone N. Metabolomics study of saw palmetto extracts based on 1H NMR spectroscopy. Fitoterapia 2015; 102: 56-60
- 42 Ruckhofer J. TCM-Drogen: Identifizierung und Charakterisierung mittels Infrarotmethoden [MD Thesis]. Wien: Universität Wien; 2011